Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-Oxy-Diarylquinoline Derivatives as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. 2019, 69, 671–682.

28 Dec 2019
0

Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-Oxy-Diarylquinoline Derivatives as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. 2019, 69, 671–682.

Tags

Share this

Related Posts

A structure-based virtual high-throughput screening, molecular docking, molecular dynamics and MM/PBSA study identified novel putative drug-like dual inhibitors of trypanosomal cruzain and rhodesain cysteine proteases
Proteomic analysis reveals plasma haptoglobin, interferon-γ, and interleukin-1β as potential biomarkers of pediatric refractory epilepsy. Saengow VE, Chiangjong W, Khongkhatithum C, Changtong C, Chokchaichamnankit D, Weeraphan C, Kaewboonruang P, Thampratankul L, Manuyakorn W, Hongeng S, Srisomsap C, Svasti J, Chutipongtanate S, Visudtibhan A. Brain Dev. 2021 Mar;43(3):431-439.

Recent Posts